Sundar PichaiSundar Pichai earned $164M in 2023

Mark J. Tarr is the CEO of Encompass Health Corporation, a role he has held since the end of 2016. He has been with the company for over 23 years, climbing the ranks from various leadership positions, showcasing his deep...

Quick Links
E

Mark J. Tarr

CEO of Encompass Health Corporation

Education

Bachelor's degree from Ball State University

Field of Expertise

Healthcare & Life Sciences - Healthcare

Sector of Economy

Healthcare

Born

December 29, 1961 - 63 years ago

CEO of Encompass Health Corporation for

8 years 3 months (Dec 2016 - Present)

Previous Experience

Executive Vice President and Chief Operating Officer at Encompass Health

Rivals

Competitors/colleagues of Mark J. Tarr

Holdings

See how much did Mark J. Tarr make over time.

Mark J. Tarr's stock holdings in Encompass Health have seen significant changes, reflecting his strong tie to the company's performance. In late 2019, his holdings were valued at approximately $21.51 million, steadily increasing to around $34.91 million by August 2023....

Loading...

Total Stock Sold

$12.94M

EHC

$12.94M

217,369 EHC shares

What if they kept their stock?

If Mark J. Tarr didn't sell their stock, today they would have:
Extra EHC217,369 shares worth $13.91M.
This is 7.47% and $966.74K more than what they got when they sold the stock.

Insider Trading

See recent insider trades of Mark J. Tarr.

EHC

$3.75M

EHC at $83.27/share

Apr 30, 2024

Sale

EHC

89,500 shares

EHC

Feb 28, 2024

Received

EHC

$1.80M

EHC at $71.06/share

Aug 16, 2023

Sale

EHC

78,327 shares

EHC

Feb 23, 2023

Received

EHC

$1.09M

EHC at $53.25/share

Aug 17, 2022

Sale

EHC

47,988 shares

EHC

Feb 24, 2022

Received

EHC

43,137 shares

EHC

Feb 23, 2021

Received

EHC

$1.62M

EHC at $61.92/share

May 14, 2020

Sale

EHC

67,304 shares

EHC

Feb 18, 2020

Received

EHC

$4.28M

EHC at $63.49/share

May 1, 2019

Sale

Compensation History

See how much did Mark J. Tarr make over time.

In 2023, Mark J. Tarr's total compensation was about $8.8 million, which included a $1.05 million salary and vesting stock worth approximately $3.28 million. His compensation structure emphasizes performance, with no bonuses awarded that year, reflecting a shift towards long-term incentives. This approach aims to correlate his earnings with the company’s performance metrics like Adjusted EBITDA and patient care quality. Comparatively, in previous years, his compensation also included significant bonuses during periods of strong company performance, demonstrating the importance of aligning executive pay with results. This philosophy ensures that Tarr's interests remain closely aligned with those of Encompass Health's shareholders, as the company's success directly impacts his total earnings.

Year

2023

Total Compensation

$4.40M

Salary

$1.05M

Board Justification

The compensation philosophy is designed to align executive compensation with performance metrics and shareholder interests, focusing on long-term value creation.

Bonus

$0.00

Board Justification

No bonus was awarded for 2023 as the focus was on long-term incentives and performance-based compensation.

Other

$66.92K

Board Justification

Other compensation includes contributions to the nonqualified 401(k) plan and other benefits.

Restricted Stock

$3.28M(54.56K RSU)

Board Justification

The stock awards that vested in 2023 were based on performance metrics achieved during the 2021-2022 performance period, with a total of 54,561 shares vesting in 2023.

Performance Metrics

The performance metrics for determining compensation include Adjusted EBITDA and quality metrics related to patient care and employee turnover.

Other Encompass Health Corporation CEOs

Here are other CEOs of Encompass Health Corporation